Proteomics: Technologies and Global Markets
Market Research Report I 2025-05-16 I 153 Pages I BCC Research
Description
Report Scope
The report analyzes trends in the global market for proteomic technologies market. It includes global revenues ($ millions) for the base year of 2024, estimates for 2025 and forecasts for 2025 through 2030. The market is segmented by product type, application, platform and region. Protein structural analysis and protein-expression products are outside the scope of the report. Product types include instruments and software, and consumables. Platforms include mass spectrometry and biochip. Applications include drug discovery and development, research, diagnostics, and applied proteomics. Regions are North America, Europe, Asia-Pacific and the Rest of the World (RoW). North America includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea and the Rest of Asia-Pacific. RoW includes the Middle East and Africa (MEA) and South America.
The report focuses on the trends and challenges that affect the market and vendor landscape. It discusses emerging technologies and includes an analysis of the market shares of the leading companies. It offers a chapter on environmental, social, and corporate governance (ESG) developments. Its section on company profiles covers details such as financials, product portfolio, and recent developments.
Report Includes
- 97 data tables and 56 additional tables
- An overview of the global markets for proteomics and related technologies
- Analyses of the global market trends, with historic market revenue data from 2022 to 2024, estimates for 2025 and projected CAGRs through 2030
- Estimates of the actual market size and forecasts for proteomics, and a corresponding market share analysis by platform type, application, product type, and region
- In-depth facts and figures concerning market dynamics, technology advances, new products and applications for proteomics
- Discussion of patents and emerging technologies
- ESG trends in the industry
- Insight into the industry structure for proteomics technologies, competitive aspects of each product segment, companies' growth strategies, and a company value share analysis
- Updated information on mergers and acquisitions, agreements, partnerships and new products in the global proteomics industry
- Profiles of the leading companies, including Thermo Fisher Scientific Inc., Danaher, Agilent Technologies Inc., Bruker and Waters Corp.
Executive Summary
Summary:
The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Overview
Current Market Scenario
Segmental Analysis
Regional Analysis
Emerging Technologies
Conclusion
Chapter 2 Market Overview
Proteomic Technologies
Types of Proteomics
Expression Proteomics
Structural Proteomics
Functional Proteomics
Proteomics Workflow
Macroeconomic Factors Analysis
Porter's Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Threat of Substitute Products or Services
Potential for New Entrants
Industry Competitiveness
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Investments in R&D
Transition To Personalized Medicines
Rising Aging Population and the Growing Prevalence of Chronic Diseases
Market Restraints
High Cost of Instruments and Lack of Skilled Workforce
Complexity of Data Analysis
Market Opportunities
Emerging Technologies
Integrative Approaches
Chapter 4 Regulatory Landscape
Regulatory Overview
Regulations in the U.S.
Regulations in Europe
Proteomics Standards Initiative
Chapter 5 Emerging Technologies and Developments
Emerging Technologies in the Proteomics Market
Advances in Mass Spectrometry
Immuno-Ligation
Single-cell Proteomics
Application of AI in Proteomics
Patent Analysis
Patents, by Top Applicants
Patents, by Assignee Country/Region
Patents, by Year
Key Takeaways
Chapter 6 Market Segmentation Analysis
Overview
Segmentation Breakdown
Market Analysis by Platform Type
Mass Spectrometry
Biochips
Market Analysis by Application
Takeaways
Drug Discovery and Development
Diagnostics
Research
Applied Proteomics
Market Analysis by Product Type
Takeaways
Consumables
Instruments and Software
Geographic Breakdown
Market Analysis by Region
Takeaways
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Competitive Intelligence
Overview
Market Ranking Analysis
Strategic Initiatives
Mergers and Acquisitions
Agreements, Collaborations and Partnerships
New Products
Chapter 8 Sustainability in the Proteomics Technology Industry: ESG Perspective
Introduction to Environmental, Social and Governance
Sustainability Trends and Initiatives
Environmental Performance
Social Performance
Governance Performance
ESG Risk Ratings
Concluding Remarks from BCC Research
Chapter 9 Appendix
Methodology
Sources
Abbreviations
Company Profiles
AGILENT TECHNOLOGIES INC.
ARRAYIT CORP.
BIO-RAD LABORATORIES INC.
BIO-TECHNE
BRUKER
CREATIVE PROTEOMICS
DANAHER CORP.
JEOL LTD.
MERCK KGAA
PROMEGA CORP.
REVVITY
SHIMADZU CORP.
STANDARD BIOTOOLS
THERMO FISHER SCIENTIFIC INC.
WATERS CORP.
Emerging Start-ups/Market Disruptors
List of Tables
Summary Table : Global Market for Proteomic Technologies, by Region, Through 2030
Table 1 : Global Incidence and Mortality Rates of Cancer, by Region, 2022
Table 2 : Granted Patents in Proteomics Technologies, 2023-2025
Table 3 : Global Market for Proteomics Technologies, by Platform Type, Through 2030
Table 4 : Global Market for Mass Spectrometry, by Region, Through 2030
Table 5 : Global Market for Biochips, by Type, Through 2030
Table 6 : Global Market for Protein Microarrays, by Array Type, Through 2030
Table 7 : Global Market for Biochips, by Region, Through 2030
Table 8 : Global Market for Proteomic Technologies, by Application Type, Through 2030
Table 9 : Drug Targets Identified by Proteomics
Table 10 : Global Market for Proteomics in Drug Discovery and Development, by Platform Type, Through 2030
Table 11 : Global Market for Proteomics in Drug Discovery and Development, by Region, Through 2030
Table 12 : Examples of LC-MS/MS-based FDA-Approved Tests in Clinical Laboratories
Table 13 : Global Market for Proteomics in Diagnostics, by Platform Type, Through 2030
Table 14 : Global Market for Proteomics in Diagnostics, by Region, Through 2030
Table 15 : Global Market for Proteomics in Diagnostics, by Disease Type, Through 2030
Table 16 : Global Market for Proteomics in Research, by Platform Type, Through 2030
Table 17 : Global Market for Proteomics in Research, by Region, Through 2030
Table 18 : Global Market for Applied Proteomics, by Region, Through 2030
Table 19 : Global Market for Proteomic Technologies, by Product Type, Through 2030
Table 20 : Global Market for Consumables, by Region, Through 2030
Table 21 : Global Market for Instruments and Software, by Region, Through 2030
Table 22 : Global Market for Proteomic Technologies, by Region, Through 2030
Table 23 : North American Market for Proteomic Technologies, by Platform Type, Through 2030
Table 24 : North American Market for Biochips, by Type, Through 2030
Table 25 : North American Market for Proteomic Technologies, by Application Type, Through 2030
Table 26 : North American Market for Proteomic Technologies, by Product Type, Through 2030
Table 27 : North American Market for Proteomic Technologies, by Country, Through 2030
Table 28 : U.S. Market for Proteomic Technologies, by Platform Type, Through 2030
Table 29 : U.S. Market for Proteomic Technologies, by Application Type, Through 2030
Table 30 : U.S. Market for Proteomic Technologies, by Product Type, Through 2030
Table 31 : Canadian Market for Proteomic Technologies, by Platform Type, Through 2030
Table 32 : Canadian Market for Proteomic Technologies, by Application Type, Through 2030
Table 33 : Canadian Market for Proteomic Technologies, by Product Type, Through 2030
Table 34 : Mexican Market for Proteomic Technologies, by Platform Type, Through 2030
Table 35 : Mexican Market for Proteomic Technologies, by Application Type, Through 2030
Table 36 : Mexican Market for Proteomic Technologies, by Product Type, Through 2030
Table 37 : European Market for Proteomic Technologies, by Platform Type, Through 2030
Table 38 : European Market for Biochips, by Type, Through 2030
Table 39 : European Market for Proteomic Technologies, by Application Type, Through 2030
Table 40 : European Market for Proteomic Technologies, by Product Type, Through 2030
Table 41 : European Market for Proteomic Technologies, by Country, Through 2030
Table 42 : German Market for Proteomic Technologies, by Platform Type, Through 2030
Table 43 : German Market for Proteomic Technologies, by Application Type, Through 2030
Table 44 : German Market for Proteomic Technologies, by Product Type, Through 2030
Table 45 : U.K. Market for Proteomic Technologies, by Platform Type, Through 2030
Table 46 : U.K. Market for Proteomic Technologies, by Application Type, Through 2030
Table 47 : U.K. Market for Proteomic Technologies, by Product Type, Through 2030
Table 48 : French Market for Proteomic Technologies, by Platform Type, Through 2030
Table 49 : French Market for Proteomic Technologies, by Application Type, Through 2030
Table 50 : French Market for Proteomic Technologies, by Product Type, Through 2030
Table 51 : Italian Market for Proteomic Technologies, by Platform Type, Through 2030
Table 52 : Italian Market for Proteomic Technologies, by Application Type, Through 2030
Table 53 : Italian Market for Proteomic Technologies, by Product Type, Through 2030
Table 54 : Spanish Market for Proteomic Technologies, by Platform Type, Through 2030
Table 55 : Spanish Market for Proteomic Technologies, by Application Type, Through 2030
Table 56 : Spanish Market for Proteomic Technologies, by Product Type, Through 2030
Table 57 : Rest of European Market for Proteomic Technologies, by Platform Type, Through 2030
Table 58 : Rest of European Market for Proteomic Technologies, by Application Type, Through 2030
Table 59 : Rest of European Market for Proteomic Technologies, by Product Type, Through 2030
Table 60 : Asia-Pacific Market for Proteomic Technologies, by Platform Type, Through 2030
Table 61 : Asia-Pacific Market for Biochips, by Type, Through 2030
Table 62 : Asia-Pacific Market for Proteomic Technologies, by Application Type, Through 2030
Table 63 : Asia-Pacific Market for Proteomic Technologies, by Product Type, Through 2030
Table 64 : Asia-Pacific Market for Proteomic Technologies, by Country, Through 2030
Table 65 : Chinese Market for Proteomic Technologies, by Platform Type, Through 2030
Table 66 : Chinese Market for Proteomic Technologies, by Application Type, Through 2030
Table 67 : Chinese Market for Proteomic Technologies, by Product Type, Through 2030
Table 68 : Japanese Market for Proteomic Technologies, by Platform Type, Through 2030
Table 69 : Japanese Market for Proteomic Technologies, by Application Type, Through 2030
Table 70 : Japanese Market for Proteomic Technologies, by Product Type, Through 2030
Table 71 : Indian Market for Proteomic Technologies, by Platform Type, Through 2030
Table 72 : Indian Market for Proteomic Technologies, by Application Type, Through 2030
Table 73 : Indian Market for Proteomic Technologies, by Product Type, Through 2030
Table 74 : South Korean Market for Proteomic Technologies, by Platform Type, Through 2030
Table 75 : South Korean Market for Proteomic Technologies, by Application Type, Through 2030
Table 76 : South Korean Market for Proteomic Technologies, by Product Type, Through 2030
Table 77 : Australian Market for Proteomic Technologies, by Platform Type, Through 2030
Table 78 : Australian Market for Proteomic Technologies, by Application Type, Through 2030
Table 79 : Australian Market for Proteomic Technologies, by Product Type, Through 2030
Table 80 : Rest of Asia-Pacific Market for Proteomic Technologies, by Platform Type, Through 2030
Table 81 : Rest of Asia-Pacific Market for Proteomic Technologies, by Application Type, Through 2030
Table 82 : Rest of Asia-Pacific Market for Proteomic Technologies, by Product Type, Through 2030
Table 83 : RoW Market for Proteomic Technologies, by Platform Type, Through 2030
Table 84 : RoW Market for Proteomic Technologies, by Application Type, Through 2030
Table 85 : RoW Market for Biochips, by Type, Through 2030
Table 86 : RoW Market for Proteomic Technologies, by Product Type, Through 2030
Table 87 : RoW Market for Proteomic Technologies, by Sub-region, Through 2030
Table 88 : Rank of Manufacturers in the Proteomics Technology Market, 2024
Table 89 : Mergers and Acquisitions in the Proteomics Technology Industry, 2020-2025
Table 90 : Agreements, Collaborations and Partnerships in the Proteomics Technology Industry, 2022-2025
Table 91 : Product Introductions in the Proteomics Technology Market, 2023-2025
Table 92 : Environmental Performance Initiatives in the Proteomics Industry
Table 93 : Social Performance Initiatives in Proteomics Market
Table 94 : Governance Performance Initiatives in the Proteomics Industry
Table 95 : ESG Rankings for Proteomics Companies, 2025*
Table 96 : Information Sources for this Report
Table 97 : Abbreviations Used in this Report
Table 98 : Agilent Technologies Inc.: Company Snapshot
Table 99 : Agilent Technologies Inc.: Financial Performance, FY 2023 and 2024
Table 100 : Agilent Technologies Inc.: Product Portfolio
Table 101 : Agilent Technologies Inc: News/Key Developments, 2023 and 2024
Table 102 : Arrayit Corp.: Company Snapshot
Table 103 : Arrayit Corp.: Product Portfolio
Table 104 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 105 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2023 and 2024
Table 106 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 107 : Bio-Rad Laboratories Inc.: News/Key Developments, 2021 and 2023
Table 108 : Bio-Techne: Company Snapshot
Table 109 : Bio-Techne: Financial Performance, FY 2022 and 2023
Table 110 : Bio-Techne: Product Portfolio
Table 111 : Bio-Techne: News/Key Developments, 2024 and 2025
Table 112 : Bruker: Company Snapshot
Table 113 : Bruker: Financial Performance, FY 2023 and 2024
Table 114 : Bruker: Product Portfolio
Table 115 : Bruker: News/Key Developments, 2022-2025
Table 116 : Creative Proteomics: Company Snapshot
Table 117 : Creative Proteomics: Product Portfolio
Table 118 : Danaher Corp.: Company Snapshot
Table 119 : Danaher Corp.: Financial Performance, FY 2023 and 2024
Table 120 : Danaher Corp.: Product Portfolio
Table 121 : Danaher Corp.: News/Key Developments, 2024
Table 122 : JEOL Ltd.: Company Snapshot
Table 123 : JEOL Ltd.: Financial Performance, FY 2022 and 2023
Table 124 : JEOL Ltd.: Product Portfolio
Table 125 : JEOL Ltd.: News/Key Developments, 2023
Table 126 : Merck KGaA: Company Snapshot
Table 127 : Merck KGaA: Financial Performance, FY 2023 and 2024
Table 128 : Merck KGaA: Product Portfolio
Table 129 : Merck KGaA: News/Key Developments, 2023 and 2024
Table 130 : Promega Corp.: Company Snapshot
Table 131 : Promega Corp.: Product Portfolio
Table 132 : Revvity: Company Snapshot
Table 133 : Revvity: Financial Performance, FY 2023 and 2024
Table 134 : Revvity: Product Portfolio
Table 135 : Revvity: News/Key Developments, 2023 and 2024
Table 136 : Shimadzu Corp.: Company Snapshot
Table 137 : Shimadzu Corp.: Financial Performance, FY 2022 and 2023
Table 138 : Shimadzu Corp.: Product Portfolio
Table 139 : Shimadzu Corp.: News/Key Developments, 2024 and 2025
Table 140 : Standard BioTools: Company Snapshot
Table 141 : Standard BioTools: Financial Performance, FY 2023 and 2024
Table 142 : Standard BioTools: Product Portfolio
Table 143 : Standard BioTools: News/Key Developments, 2024
Table 144 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 145 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 146 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 147 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022-2025
Table 148 : Waters Corp.: Company Snapshot
Table 149 : Waters Corp.: Financial Performance, FY 2023 and 2024
Table 150 : Waters Corp.: Product Portfolio
Table 151 : Waters Corp.: News/Key Developments, 2023 and 2024
Table 152 : Emerging Startups in the Global Proteomics Market
List of Figures
Summary Figure : Share of Global Market for Proteomic Technologies, by Region, 2024
Figure 1 : Bottom-Up and Top-Down Proteomics
Figure 2 : Porter's Five Forces Analysis of the Market for Proteomic Technologies
Figure 3 : Market Dynamics for Proteomics Technologies
Figure 4 : Average Venture Funding for Biopharma Therapeutics and Platform Companies, 2010-2024
Figure 5 : Pharmaceutical R&D Expenditures for the U.S., Europe, Japan and China, for 2010, 2020 and 2022
Figure 6 : Personalized Medicines and All FDA Approvals, 2015-2023
Figure 7 : Patents Related to Proteomics, by Applicant, 2021-March 2025
Figure 8 : Share of Patents Related to Proteomics, by Country/Region, 2021-March 2025
Figure 9 : Patents Related to Proteomics, by Year, 2010-March 2025
Figure 10 : Share of Global Market for Proteomics Technologies, by Platform Type, 2024
Figure 11 : Share of Global Market for Proteomics Technologies, by Application Type, 2024
Figure 12 : Share of Global Market for Proteomics Technologies, by Platform Type, 2024
Figure 13 : Share of Global Market for Proteomic Technologies, by Region, 2024
Figure 14 : Share of North American Market for Proteomic Technologies, by Country, 2024
Figure 15 : NIH Funding in Healthcare R&D, 2010-2023
Figure 16 : Share of European Market for Proteomic Technologies, by Country, 2024
Figure 17 : Share of Asia-Pacific Market for Proteomic Technologies, by Country, 2024
Figure 18 : Share of RoW Market for Proteomic Technologies, by Sub-region, 2024
Figure 19 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2024
Figure 20 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2024
Figure 21 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2024
Figure 22 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2024
Figure 23 : Bio-Techne: Revenue Share, by Business Unit, FY 2023
Figure 24 : Bio-Techne: Revenue Share, by Country/Region, FY 2023
Figure 25 : Bruker: Revenue Share, by Business Unit, FY 2024
Figure 26 : Bruker: Revenue Share, by Country/Region, FY 2024
Figure 27 : Danaher Corp.: Revenue Share, by Business Unit, FY 2024
Figure 28 : Danaher Corp.: Revenue Share, by Country/Region, FY 2024
Figure 29 : JEOL Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 30 : JEOL Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 31 : Merck KGaA: Revenue Share, by Business Unit, FY 2024
Figure 32 : Merck KGaA: Revenue Share, by Country/Region, FY 2024
Figure 33 : Revvity: Revenue Share, by Business Unit, FY 2024
Figure 34 : Revvity: Revenue Share, by Country/Region, FY 2024
Figure 35 : Shimadzu Corp.: Revenue Share, by Business Unit, FY 2023
Figure 36 : Shimadzu Corp.: Revenue Share, by Country/Region, FY 2023
Figure 37 : Standard BioTools: Revenue Share, by Business Unit, FY 2024
Figure 38 : Standard BioTools: Revenue Share, by Country/Region, FY 2024
Figure 39 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2024
Figure 40 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2024
Figure 41 : Waters Corp.: Revenue Share, by Business Unit, FY 2024
Figure 42 : Waters Corp.: Revenue Share, by Country/Region, FY 2024
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.